More on CHGCY
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $30.75 |
|
|||
| Open | $29.86 | ||||
| 52 Wk High | $74.63 | ||||
| 52 Wk Low | $56.80 | ||||
| Day High | $30.74 | ||||
| Day Low | $28.97 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 84,175 | ||||
- New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools
- Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
- Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
- Genentech to Present New Data From Its Broad and Innovative Hematology Portfolio at ASH 2025
- Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
- Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test
- Roche gets CE mark for glucose monitor and mySugr app integration
- Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
- Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
- Roche's first respiratory test powered by TAGS technology receives FDA clearance for SARS-CoV-2, Influenza A, Influenza B and RSV
Entities mentioned with CHGCY
- FDA | View Related Stories »
- Industrial Production | View Related Stories »
- Twitter | View Related Stories »
- S1 | View Related Stories »
- Definitive Agreement | View Related Stories »
- AdCom | View Related Stories »
- Deutsche Bank | View Related Stories »
- Earnings | View Related Stories »
- Show More...
